Pages that link to "Q81247840"

The following pages link to Equivalent switching dose from oral risperidone to risperidone long-acting injection: a 48-week randomized, prospective, single-blind pharmacokinetic study (Q81247840):

Displaying 32 items.

• Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review (Q33589087) (← links)
• Long-acting risperidone: a review of its role in the treatment of bipolar disorder (Q33886093) (← links)
• Neuroanatomical circuitry associated with exploratory eye movement in schizophrenia: a voxel-based morphometric study (Q34047121) (← links)
• Convergent evidence from multimodal imaging reveals amygdala abnormalities in schizophrenic patients and their first-degree relatives (Q34103384) (← links)
• A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting (Q34174609) (← links)
• Pharmacokinetics of olanzapine long-acting injection: the clinical perspective (Q34293855) (← links)
• Error processing network dynamics in schizophrenia (Q34380342) (← links)
• The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal. (Q34418847) (← links)
• Influence of emotional processing on working memory in schizophrenia (Q35177070) (← links)
• Long acting injection versus oral risperidone in first-episode schizophrenia: differential impact on white matter myelination trajectory (Q35211261) (← links)
• Sleep and circadian rhythm disruption in schizophrenia (Q35864323) (← links)
• Comparison of the peak-to-trough fluctuation in plasma concentration of long-acting injectable antipsychotics and their oral equivalents (Q36235106) (← links)
• Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia (Q36597061) (← links)
• Risperidone long-acting injection: safety and efficacy in elderly patients with schizophrenia (Q36873892) (← links)
• Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study (Q37220015) (← links)
• Progress in compliance research and intervention: a commentary (Q37236153) (← links)
• Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia. A Randomized Clinical Trial (Q37341552) (← links)
• Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials (Q37451403) (← links)
• Long-acting atypical injectable antipsychotics in the treatment of schizophrenia: safety and tolerability review (Q37778398) (← links)
• Oral versus Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Special Populations at Risk for Treatment Nonadherence: A Systematic Review (Q38042430) (← links)
• Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia. (Q38851847) (← links)
• Compromised small-world efficiency of structural brain networks in schizophrenic patients and their unaffected parents (Q41152632) (← links)
• Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia (Q41656775) (← links)
• Applying long-acting injectable antipsychotics in first-episode schizophrenia to achieve first remission (Q46750878) (← links)
• Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study (Q48219402) (← links)
• Clozapine protects bone mineral density in female patients with schizophrenia. (Q51399396) (← links)
• Correlations between exploratory eye movement, hallucination, and cortical gray matter volume in people with schizophrenia. (Q55692230) (← links)
• Effects of long-acting injectable antipsychotics versus oral antipsychotics on autonomic nervous system activity in schizophrenic patients (Q57074533) (← links)
• Sleep and Circadian Rhythm Disturbance in Remitted Schizophrenia and Bipolar Disorder: A Systematic Review and Meta-analysis (Q90185131) (← links)
• Attitudes of European physicians towards the use of long-acting injectable antipsychotics (Q90310120) (← links)
• Use of therapeutic drug monitoring of risperidone microspheres long-acting injection in hemodialysis: A case report (Q92134538) (← links)
• Frontostriatal functional connectivity and striatal dopamine synthesis capacity in schizophrenia in terms of antipsychotic responsiveness: an [18F]DOPA PET and fMRI study (Q93262850) (← links)